Anika Therapeutics, Inc. Annual Operating Margin in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Anika Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from 2016 to 2023.
  • Anika Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2024 was -58.9 %, a 215% decline year-over-year.
  • Anika Therapeutics, Inc. annual Operating Margin for 2023 was -52.6 %, a 324% decline from 2022.
  • Anika Therapeutics, Inc. annual Operating Margin for 2022 was -12.4 %, a 802% decline from 2021.
  • Anika Therapeutics, Inc. annual Operating Margin for 2021 was 1.77 %.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -52.6 -40.2 -324% Jan 1, 2023 Dec 31, 2023
2022 -12.4 -14.2 -802% Jan 1, 2022 Dec 31, 2022
2021 1.77 +23.5 Jan 1, 2021 Dec 31, 2021
2020 -21.7 -51.6 -173% Jan 1, 2020 Dec 31, 2020
2019 29.9 +9.28 +45% Jan 1, 2019 Dec 31, 2019
2018 20.6 -19.7 -48.9% Jan 1, 2018 Dec 31, 2018
2017 40.3 -8.63 -17.6% Jan 1, 2017 Dec 31, 2017
2016 49 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.